Abstract. Currently, cell separation occurs almost exclusively by density gradient methods and by fluorescence-and magnetic-activated cell sorting (FACS/MACS). These variously suffer from lack of specificity, high cell loss, use of labels, and high capital/operating cost.
High-Throughput, Low-Loss, Low-Cost and Label-Free Cell Since the separation of red and white blood cells was first reported in 1974 (1), the technology has become fundamental in the biomedical sciences. From isolation of diseased tissue to the identification of cells for therapeutic uses and the potential for regenerative cell based therapies, cell separation techniques are increasingly integrated into other fields such as biochemistry, electrical engineering, physics and materials science (2) . Three methods dominate cell separation. Density gradient methods exploits differences in density between populations such as red/white blood cells. Fluorescently-activated cell sorting (FACS) uses fluorophore-conjugated antibodies as a discriminator; cells are launched in droplets, each containing one cell, through a fluorescence detection system to determine the cell type and are then electrostatically diverted into different output receptacles (3) . FACS can sort up to 50,000 cells per second, with higher rates achievable at the cost of purity. Finally, magnetically-activated cell sorting (MACS) uses magnetic microbeads conjugated with antibodies. These bind to targets on cell surfaces, which then can be extracted by applying a magnetic field (4) . However, the three methods have drawbacks. Only density gradient does not require the use of chemical labels; the others use fluorescent chemicals or antibodies to indicate the target population. These are expensive and may have limited specificity; in the case of MACS, the target protein must be present on the surface of the cells. Following separation, the labels may also persist in the cells, limiting their usefulness. Cell losses in FACS and MACS can exceed half the population, particularly at high sorting rates (5, 6) . FACS machines (particularly high-throughput devices) are very expensive and are not easily cleaned, rendering cell populations separated by this method non-compliant with good manufacturing practice (GMP). Finally, as the cell preparation includes a period during which labels are added and then given sufficient time to conjugate, the total time to perform the sort can extend over several hours.
There have been many attempts to develop cell separation techniques that are affordable to buy and use, do not require labels, and are able to retain significant numbers of cells. An alternative separation technique is dielectrophoresis (DEP). A polarisable particle suspended in a non-uniform electric field (7) interacts with the field gradient, inducing a dipole. The interaction of dipole and field gradient produces different Coulomb force on either pole, inducing motion up or down the high field gradient according to the polarity of the dipole.
The magnitude and polarity of the dipole itself is governed by the electrical properties of the cell (resistance and capacitance of membrane and cytoplasm) and medium, and the frequency of the electric field. DEP can be used both to characterize and separate cells according to the passive electrical properties; where two cell types experience a field gradient at a frequency such that one cell type is attracted to the electrodes, one repelled. The repelled cells pass through the device unaffected, but the others are attracted to, and retained by, the electrodes acting as an "electrostatic filter". When the field is removed, these cells are released and can be collected separately. For example, Figure 1 shows spectra of two identical cell types, save that one has double the membrane capacitance of the other. The highlighted frequency range indicates where one cell types experiences positive DEP, the other negative. DEP spectra can be determined by commercial devices such as the DEPtech 3DEP, and exploitable differences can be readily identified by visual inspection. with purity in excess so 93%; however, the total capacity of the device was only 50µl, limiting overall throughput.
An alternative approach to DEP separation used 3D chips constructed from interleaved conducting and insulating sheets with holes or "wells" drilled through (25) . The first prototype sorted 50:50 live and dead yeast to 86:14 at 0.4 ml min -1 . A subsequent design (26) included remixing by passing a through multiple wells, producing high cell recovery (>90) but low throughput (25µl min -1 ).
To be comparable to FACS or MACS requires cell sorting at rates in excess of 10 5 s -1 with minimal cell loss, high purity, low cost and highly robust.
Here we describe an electrophysiology-activated cell enrichment (EPACE) method employing a chip with 397 holes of 400 µm diameter drilled through a laminate of 12 conducting layers separated by insulators, though which 397 wells with 400 µm diameter were drilled. As shown in figure 2, this creates 397 parallel paths through the chip, each with 12 electrodes along the bore. This high degree of parallelization, and the fact that all cells are no more than 200 µm from the electrodes, allows very high cell processing rates whilst minimising cell loss, and creates immunity from bubbles (which will, at worst, block only one channel). Consequently, the system can separate cells at rates substantially in excess of 320,000 cells s yielded similar results, suggesting these metrics represented a plateau of trapping efficiency, and that the device was working well within its performance limit.
To assess the viability of cells post-sort, collected fibroblasts were suspended in fibroblast growing medium, divided into two T75 flasks and placed in the incubator to assess growth potential. The cells were observed 1 and 3 days after incubation and were found to have adhered to the flask and reached confluency respectively. A DEP spectrum of the cells was obtained and a further passage performed to check for abnormalities and none were observed.
In order to identify the upper throughput limit, live yeast cells were captured in the device in 
High-volume separation performance using multi-pass protocols
Whilst enrichment on this scale is of interest, a second or third pass through the device enables the user to collect cells that were not retained in previous passes, significantly improving performance in a very short time. There are two strategies for multiple sorting passes; re-sorting the effluxed and retained cells, respectively. Here we examine these two protocols separately; a two-pass strategy re-processing the effluxed cells to minimise cell loss whilst maximising enrichment in the shortest possible time, and a three-pass strategy where the collected cells are re-processed.
Enhancing the negative DEP population. We sorted mixtures of 9.6 -14 x 10 After the second pass the purity of dead yeast was increased to 93.4%; whilst the RBC fraction increased to 93.8%. However, recovery was reduced, falling to 81% and 73.7%
respectively, though these are still substantially above recovery rates for FACS and MACS.
Overall cell losses (cells not appearing in either outlet) were 2.7% and 4%, with the remaining cells appearing in the other (waste) output. We postulated that the values of separation efficiency for the populations experiencing negative DEP were adversely affected by cells being trapped in the dead volume between the chip and outlet, which were then recovered with the retained cells rather than passing to the effluxed portion. In order to verify this we performed a separation of 20ml of RBC/fibroblast c e l l s a t t h e s a m e concentration. After the second pass, the recovery of RBCs was broadly similar at 87.8%, but the purity raised to 96.6%.
Enhancing the positive DEP population. An important application of cell separation is the enrichment of relatively rare subpopulations. In order to use the EPACE platform to enrich highly asymmetrical cell concentrations a 3-pass strategy was used, with the cell fraction retained in the electrodes being retrieved and then subject to two further iterations (total time taken ca. 30 minutes). The cells collected were counted after each pass, and the ratio of cell types was determined. These results are summarised in , to a total sample volume of 4ml. Cells were passed through the device at 0.5 ml min -1
. After the cells mixture had completed its first pass through the device, the fraction retained in the device was released in 1ml of fresh medium which was topped up to 3 ml with fresh medium after cell counting.
Sampling indicated that the concentration of RBCs had dropped to 95.5% of the output. The Whilst purity of sample at output is the final arbiter of the quality of a separation/enrichment method, it is difficult to use as a guide as it depends on the concentration of the two cell types at the input. Instead, we can look at the concentration of both the desired and undesired cells. and deposit them in the output to population B. Whilst a future embodiment of the device could reduce the dead volumes by redesigning the plunger and outlet path, we can calculate the effective peak separation by mathematically removing the cells in the dead volumes. We estimate that using this approach, the recovery of RBCs and purity of fibroblasts in the separation described above would equal or exceed the same parameters for the two parameters unaffected by the dead volumes, which is to say that all purities and recoveries would exceed 95% for a two-pass strategy.
The design outlined in this paper is a proof of concept, but a number of design modifications suggest themselves to improve simplicity, throughput, and capacity. For example, the device presented here is loaded manually by drawing the syringe plunger upwards. This means there is little control of the flow rate during loading; hence, during this time, the chip is not energised. However with the application of a bidirectional syringe pump that can both push and pull, it would be possible to separate on both draw and expel cycles, making separation 
Comparison to other separation methods
As described earlier, cell separation methods requiring more sensitivity than density gradients can be addressed by two methods; FACS and MACS. A high throughput FACS system is expensive; both FACS and MACS require expensive labels, and can only separate cells on the basis of this labelling. The EPACE system presented here separates on the basis of physical parameters without the need for labels, and both the instrumentation (pump and generator) and consumables required (media, chips) are an order of magnitude less expensive than either method. Furthermore, the system presented here could be manufactured as a fully assembled, sterile, integrated cartridge; with no crossover possible with other reparation runs, and no residual chemical labels to adversely affect cells, this allows the cells produced to be fully compliant with Good Manufacturing Practice (GMP).
Cell throughput rates also compare well with other methods. High throughput FACS cell sorters can process up to 100,000 events per second, though a relatively small proportion of these may actually contain cells. MACS is a bulk method rather than processing cells serially, but the time taken to prepare and perform separation is comparable to the method the case of the rare cell study, still gives a nett throughput comparable to high-throughput FACS. Considering cell loss, EPACE is shown to be comparable to, or better than, either existing method. In no case were more than 7% of cells lost, and in many cases fewer than 3% of cells were lost. By comparison, FACS typically loses >50% of cells through cell damage during droplet formation or rejection due to incorrect scanning, particularly at higher flow rates (5) . When used in three-pass mode, cell recovery was lower, but the cells not initially captured by the device will be available for re-sorting in the outlet stream by using a more complex multiple-run separation strategy.
Comparing our method to published DEP methods, the EPACE process is 30x faster than the Hu et al. (22) system, 6x faster than the Gupta et al. (21) system, and 600x faster than the system presented by Lee (23), with comparable or better cell recovery and cell losses. The cell concentration and recovery were comparable to the Markx et al. system (24); without additional data we cannot compare throughput or cell loss. As th e s e d e v i c e s w e r e microfluidic, we suggest that the system presented here should be significantly more robust;
whereas the function of planar microfluidic devices can be compromised by the presence of a single bubble, the highly parallel design of our chip means that if a bubble appears it has no more effect potentially blocking just one of the 397 holes. In conclusion, we have presented a DEP-based cell separation technique that has a capacity and throughput comparable to the fastest MACS and FACS machines, requires no chemical labels, offers GMP compatibility, significantly lower cell loss, and significantly lower capital and running costs. Given the opportunity to exploit differences in cell electrophysiology in fields such as stem cell therapy and cancer, we believe this offers significant promise as a new standard benchtop laboratory technique.
Materials and Methods
Experiments followed the steps outlined in figure 6 . . One cell type is retained in the electrodes whilst the other is eluted. In step 3, after the solution is fully expelled, fresh medium is drawn into the device and expelled manually at a higher rate, whilst the retaining field is deactivated, allowing the retained cells to be collected. were sourced from the University of Surrey's breeding colony in the UK, which was based on animals kindly donated by Professor Gerkema, University of Groningen, The Netherlands (S1-S3). Whole vole blood (1ml) was collected following published protocols (S4) using cardiac puncture, and collected in heparin coated tubes. Collection was followed by RBC isolation though three identical centrifugation steps (10 minutes, 1620g, 4C), each followed by resuspension of the RBC containing pellet in Phosphate Buffered Saline. Finally, the two cell types were mixed and resuspended in DEP medium comprising de-ionised water supplemented with 8.5/0.3 % sucrose/dextrose (Sigma-Aldrich, U.K.), which were then washed and resuspended in DEP medium. The medium had a similar conductivity to the DI water sample described above. , to a total sample volume of 4ml.
Device Fabrication
The device comprised three principal parts; a fluidic chip, a casing, and the support instrument (including principally a signal generator, amplifier, and syringe driver). The chip comprised ten layers of 70µm-thick copper separated by 150 µm-thick glass fibre reinforced epoxy (FR4) layers, with two further 35 µm-thick copper layers at the top and bottom. All copper layers were patterned in a circle slightly larger than the area through which the separation wells were drilled, to minimise overlap and associated capacitive losses. 397 wells with a 400µm-diameter were drilled in a hexagonal pattern at the centre of the chip;
larger holes for assembly and contacts were placed at the perimeter of the chip. Exposed copper areas were gold-plated to maintain stability and biocompatibility. The chip was housed in a cartridge machined from PMMA, which comprised a reservoir containing a syringe plunger from a 20ml syringe, a chip holder, and an outlet. The chip formed the base of the reservoir, such that when the plunger was pushed, cells were able to flow through all 397 holes. Below the chip, a collection cone funnelled the suspension into a 1.46mm
diameter outlet tube to a collection receptacle. The chip was mounted between top cylinder and bottom cone of the assembly and secured using Allen bolts, with a watertight seal provided by two 19.13mm-diameter O-rings.
